NOI_Sole Source_Agilent Technologies_SAM.gov.pdf

Intent to Sole Source – Agilent Technologies, LLC – 5800 Inductively Coupled Plasma Optical

Emission Spectroscopy (ICP-OES)

The Centers for Disease Control and Prevention (CDC), National Institute for Occupational

Safety and Health (NIOSH), Health Effects Laboratory Division (HELD), Chemical and

Biological Monitoring Branch (CBMB) hereby announces its intent to issue an award, sole source, firm fixed-price purchase order to Agilent Technologies, LLC, 2850 Centerville RD, Wilmington, Delaware, 19808-1610.

Agilent Technologies, LLC is the only vendor able to provide the Agilent 5800 ICP-OES instrument, an autosampler rack, a recirculating chiller, calibration blanks and solution, tubing, and on-site training and installation. The Agilent Technologies 5800 ICP-OES with the necessary features and specifications that will meet the requirement. The instrumentation has a vertical torch with quick change mount, fixed injector, and dual viewing. The Agilent 5800 ICP-

OES possess a simultaneous polychromator with no moving parts. The instrumentation also inlcudes a simultaneous and sealed Charge-Coupled Device (CCD) detector with full wavelength coverage. The CCD detectors are maintenance free and don’t require an extended gas purge to be ready for analysis. The combination of key instrument features and specifications is only available on the Agilent 5800 ICP-OES.

This contract action for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.103-1 and 10 U.S.C. 3204(a)(1).

The sole source procurement will be awarded as a simplified acquisition in accordance with FAR

Part 12 – Acquisition of Commercial Products and Commercial Supplies. The NAICS code for this request is 334516 - Manufacturing Analytical Laboratory Instruments and Instrumentation

Systems.

THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS;

however, all responses received within 15 days of the issuance of this notice will be reviewed by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Interested parties who believe they possess the capabilities to satisfy this requirement should submit a capability statement demonstrating their abilities to meet this requirement. Any response must be emailed to the contract specialist Felipe Cardenas at tpp5@cdc.gov by August 26, 2026. No phone calls will be accepted.

mailto:tpp5@cdc.gov